ContractClinical Trial Agreement • April 19th, 2024
Contract Type FiledApril 19th, 2024SMLOUVAO KLINICKÉM HODNOCENÍ CLINICAL TRIAL AGREEMENT Mezi Among Společností IONIS Pharmaceuticals, Inc., se sídlem 2855 Gazelle Court, Carlsbad, CA 92010, USA (dále jen „Zadavatel“), jejíž autorizovaným zástupcem pro EU je IONIS Development (Ireland) Limited, 10 Earlsfort Terrace, Dublin 2, D02 T380, Irsko IONIS Pharmaceuticals, Inc., with its principal office and place of business at 2855 Gazelle Court, Carlsbad, CA 92010, USA (hereinafter referred to as the “Sponsor”), whose authorized representative for the EU is Ionis Development (Ireland) Limited, 10 Earlsfort Terrace, Dublin 2, D02 T380, Ireland A AND společností Medpace Clinical Research, LLC, se sídlem a místem podnikání na adrese 5375 Medpace Way, Cincinnati, Ohio 45227, USA zastoupenou:, manažerem klinickéhohodnocení (dále jen „Medpace“) Medpace Clinical Research, LLC, with its principal office and place of business at 5375 Medpace Way, Cincinnati, Ohio 45227, USA Represented by: ,Clinical Trial Manager (hereinafter refe